Structure Therapeutics Inc. entered into a share purchase agreement with institutional investors for a private placement transaction, issuing a total of 21,617,295 ordinary shares and 2,401,920 non-voting ordinary shares for gross proceeds of approximately $300 million, with the proceeds to be used for development and other corporate purposes.